Flaherty Gerard Thomas, Hession Paul, Liew Chee Hwui, Lim Bryan Chang Wei, Leong Tan Kok, Lim Victor, Sulaiman Lokman Hakim
School of Medicine, National University of Ireland Galway, Galway, Ireland.
National Institute for Prevention and Cardiovascular Health, Galway, Ireland.
Trop Dis Travel Med Vaccines. 2020 Aug 28;6:16. doi: 10.1186/s40794-020-00118-y. eCollection 2020.
A high burden of severe disease and death from the coronavirus disease 2019 (COVID-19) has been consistently observed in older patients, especially those with pre-existing medical co-morbidities. The global pandemic lockdown has isolated many patients with chronic illnesses from their routine medical care. This narrative review article analyses the multitude of issues faced by individuals with underlying medical conditions during the COVID-19 pandemic.
Sources for this publication were identified through searches of PubMed for articles published between 31st December 2019 and 4th June 2020, using combinations of search terms. Guidelines and updates from reputable agencies were also consulted. Only articles published in the English language were included.
The volume of literature on COVID-19 continues to expand, with 17,845 articles indexed on PubMed by 4th June 2020, 130 of which were deemed particularly relevant to the subject matter of this review. Older patients are more likely to progress to severe COVID-19 disease requiring intensive care unit (ICU) admission. Patients with pre-existing cardiovascular disease, especially hypertension and coronary heart disease, are at greatly increased risk of developing severe and fatal COVID-19 disease. A controversial aspect of the management of COVID-19 disease has been the use of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers. Obese COVID-19 patients are more likely to require complex ICU management. Putative mechanisms of increased COVID-19 disease severity in diabetes include hyperglycaemia, altered immune function, sub-optimal glycaemic control during hospitalisation, a pro-thrombotic and pro-inflammatory state. Patients with mental health disorders are particularly vulnerable to social isolation, and this has been compounded by the suspension of non-emergency care in hospitals around the world, making it difficult for patients with chronic mental illness to attend outpatient appointments.
The global pandemic of COVID-19 disease has had a disproportionately negative impact on patients living with chronic medical illness. Future research should be directed at efforts to protect vulnerable patients from possible further waves of COVID-19 and minimising the negative impact of pandemic mitigation strategies on these individuals.
2019冠状病毒病(COVID-19)导致的严重疾病和死亡负担在老年患者中一直居高不下,尤其是那些有基础疾病的患者。全球大流行封锁使许多慢性病患者无法获得常规医疗护理。这篇叙述性综述文章分析了COVID-19大流行期间有基础疾病的个体所面临的众多问题。
通过在PubMed上搜索2019年12月31日至2020年6月4日期间发表的文章来确定本出版物的资料来源,使用了搜索词组合。还查阅了知名机构的指南和更新内容。仅纳入以英文发表的文章。
关于COVID-19的文献数量持续增加,截至2020年6月4日,PubMed上索引的文章有17,845篇,其中130篇被认为与本综述的主题特别相关。老年患者更有可能进展为需要入住重症监护病房(ICU)的严重COVID-19疾病。有心血管疾病史的患者,尤其是高血压和冠心病患者,发生严重和致命COVID-19疾病的风险大大增加。COVID-19疾病管理中一个有争议的方面是血管紧张素转换酶抑制剂和血管紧张素受体阻滞剂的使用。肥胖的COVID-19患者更有可能需要复杂的ICU管理。糖尿病患者中COVID-19疾病严重程度增加的推定机制包括高血糖、免疫功能改变、住院期间血糖控制不佳、促血栓形成和促炎状态。患有精神疾病的患者特别容易受到社会隔离的影响,而全球各地医院暂停非紧急护理使这种情况更加复杂,导致慢性精神疾病患者难以就诊。
COVID-19疾病的全球大流行对患有慢性疾病的患者产生了不成比例的负面影响。未来的研究应致力于保护脆弱患者免受COVID-19可能的后续浪潮影响,并尽量减少大流行缓解策略对这些个体的负面影响。